954PHOXA9 methylation in circulating tumor DNA as a prognostic biomarker in BRCA-mutated ovarian cancer patients treated with PARP inhibitor
Rusan, M, Fredslund Andersen, R, Jakobsen, A, Steffensen, K DТом:
29
Журнал:
Annals of Oncology
DOI:
10.1093/annonc/mdy285.162
Date:
October, 2018
Файл:
PDF, 76 KB
2018
File converter
Більше результатів пошуку
More benefits 
